IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.

about

IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.

Item

http://www.wikidata.org/entity/Q48595265

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@en

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@nl

type

Item

label

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@en

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@nl

prefLabel

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@en

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@nl

P1476

IDH1 Mutation Is an Independen ...... ith Myelodysplastic Syndromes.

@en

P2093

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Hongzhi Xu

http://www.w3.org/2001/XMLSchema#string

Na Wang

http://www.w3.org/2001/XMLSchema#string

Ningning Shan

http://www.w3.org/2001/XMLSchema#string

Xiaohui Sui

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Recurring mutations found by sequencing an acute myeloid leukemia genome

IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

P304

143-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000479546

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28873367

http://www.w3.org/2001/XMLSchema#string